These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7841871)

  • 1. The treatment of stimulant dependence.
    Schuckit MA
    Addiction; 1994 Nov; 89(11):1559-63. PubMed ID: 7841871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention of stimulant misuse.
    Kaplan CD; Husch JA; Bieleman B
    Addiction; 1994 Nov; 89(11):1517-21. PubMed ID: 7841865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory toxicities from stimulant use.
    Albertson TE; Walby WF
    Clin Rev Allergy Immunol; 1997; 15(3):221-41. PubMed ID: 9358986
    [No Abstract]   [Full Text] [Related]  

  • 4. Addictiveness of central stimulants.
    Dackis CA; Gold MS
    Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes.
    Regier PS; Kampman KM; Childress AR
    Handb Exp Pharmacol; 2020; 258():299-322. PubMed ID: 32193666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits.
    Reske M; Eidt CA; Delis DC; Paulus MP
    Biol Psychiatry; 2010 Oct; 68(8):762-9. PubMed ID: 20605137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of stimulant drugs in a community sample of drug users.
    Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J
    Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant-induced hyperthermia and ice-water submersion: Practical considerations.
    Richards JR; Colby DK
    Clin Toxicol (Phila); 2016; 54(1):69-70. PubMed ID: 26515112
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter in response to: "Stimulant-induced hyperthermia and ice-water submersion: practical considerations".
    Laskowski LK; Landry A; Vassallo SU; Hoffman RS
    Clin Toxicol (Phila); 2016; 54(1):71. PubMed ID: 26574142
    [No Abstract]   [Full Text] [Related]  

  • 11. Mazindol treatment for cocaine dependence.
    Stine SM; Krystal JH; Kosten TR; Charney DS
    Drug Alcohol Depend; 1995 Oct; 39(3):245-52. PubMed ID: 8556974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychostimulants.
    Sanchez-Ramos JR
    Neurol Clin; 1993 Aug; 11(3):535-53. PubMed ID: 8104314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study.
    Hildt E; Lieb K; Bagusat C; Franke AG
    Biomed Res Int; 2015; 2015():621075. PubMed ID: 26064931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The costs of crime associated with stimulant use in a Canadian setting.
    Enns B; Krebs E; DeBeck K; Hayashi K; Milloy MJ; Richardson L; Wood E; Nosyk B
    Drug Alcohol Depend; 2017 Nov; 180():304-310. PubMed ID: 28942287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responding to global stimulant use: challenges and opportunities.
    Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R
    Lancet; 2019 Nov; 394(10209):1652-1667. PubMed ID: 31668409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes of stimulant misusers: one year follow-up results from the national treatment outcome research study (NTORS).
    Gossop M; Marsden J; Stewart D
    Addict Behav; 2000; 25(4):509-22. PubMed ID: 10972443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results.
    McKay JR; Alterman AI; Cacciola JS; Rutherford MJ; O'Brien CP; Koppenhaver J
    J Consult Clin Psychol; 1997 Oct; 65(5):778-88. PubMed ID: 9337497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant withdrawal.
    Lago JA; Kosten TR
    Addiction; 1994 Nov; 89(11):1477-81. PubMed ID: 7841859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.